SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA-based vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today that Dr. Robert Goodenow, former vice president, corporate development, will be part of an expert panel titled “Developing Strategic Partnerships to Propel Commercialization” at the Vaccine Development Summit being held May 23-24, 2007, at the Hilton Philadelphia City Avenue in Philadelphia, PA.
